Vaping cessation medication is emerging as a pivotal tool in the fight against nicotine addiction, especially among teens and young adults.A recent clinical trial revealed that participants aged 16 to 25 who used varenicline, an FDA-approved smoking cessation pill, had more than three times the success rate of quitting vaping compared to those who received a placebo.